Back to company

Organon Denmark ApS: Financial statements 2022

CVR: 41193093

Organon Denmark ApS (CVR 41193093) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 61,971,000 and a net result of DKK 2,139,000 compared with DKK 857,000 the year before. That is an increase of 21.6% compared with the year before. The profit margin was 3.5%. Equity amounted to DKK 26,558,000. The solvency ratio was 60.4%. The company had 16 employees in the financial year.

Revenue
61,971,000 kr.
Gross Profit
11,941,000 kr.
Profit/Loss
2,139,000 kr.
Equity
26,558,000 kr.
Total Assets
44,003,000 kr.
Employees
16

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202262 mio.11.9 mio.2.1 mio.26.6 mio.16
202151 mio.8.6 mio.857 t.24.4 mio.13
202049.2 mio.4.4 mio.1.3 mio.22.7 mio.5

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Organon Denmark ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Organon Denmark ApS: The 2021 annual report is outJul 14, 2022

Organon Denmark ApS has published its annual report for 2021. Revenue came to DKK 50,982,000, and the net result was DKK 857,000.

About Organon Denmark ApS

Organon Denmark ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Karl Johan Sundt, Sofia Raquel Paulos Ferreira Alves da Silva and Anne Bitzer. The company is owned by OBS Human Health Holding B.V.. In 2025, the company reported revenue of DKK 61,554,000 and a net result of DKK 3,139,000 compared with DKK 2,428,000 the year before. Equity amounted to DKK 31,049,000.

Other financial years